TELOMERE SHORTENING
Clinical trials for TELOMERE SHORTENING explained in plain language.
Never miss a new study
Get alerted when new TELOMERE SHORTENING trials appear
Sign up with your email to follow new studies for TELOMERE SHORTENING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests cell therapy for rare blood disorder
Disease control OngoingThis early-stage study is testing the safety of an experimental cell therapy called EXG34217 in up to 12 patients with a rare genetic disorder that causes bone marrow failure. The therapy involves collecting a patient's own blood cells, modifying them in a lab to potentially leng…
Matched conditions: TELOMERE SHORTENING
Phase: PHASE1 • Sponsor: Elixirgen Therapeutics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 02:12 UTC
-
Can diet and exercise slow cellular aging? new study investigates
Knowledge-focused OngoingThis study aims to understand how nutritional counseling and combined exercise training affect markers of cellular aging in older women. It will involve 80 women aged 60-75, comparing those with normal weight and obesity. Researchers will measure changes in cell health, inflammat…
Matched conditions: TELOMERE SHORTENING
Phase: NA • Sponsor: University of Sao Paulo • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC